The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance of technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Internet of Things in Medical Devices: Remote EEG/ECG monitoring.

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

150+ innovations will shape the medical devices industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, ingestible sensors, wireless gastric stimulation devices, and remote nerve stimulation devices are disruptive technologies that are in the early stages of application and should be tracked closely. dosage monitoring inhalators, programmable infusion pumps, and athletic monitoring sensors are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are blood glucose sensors and medical emergency response systems, which are now well established in the industry. 

Innovation S-curve for Internet of Things in the medical devices industry

Remote EEG/ECG monitoring allows physicians to measure a patient's heart rhythm/electrical activity of the brain over a period of time using wireless remote access. This technology acts as a key component to minimizing patients time in a healthcare facility, and maximizing their time in their own homes. This is showing a reduction in the number of hospital visits and improved health in patients, due to quicker reaction times to adverse events.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 110+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of remote EEG/ECG monitoring.

Key players in remote EEG/ECG monitoring – a disruptive innovation in the medical devices industry

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to remote EEG/ECG monitoring

Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies
Samsung Group 277 Unlock company profile
Apple 186 Unlock company profile
NIKE 132 Unlock company profile
Sony Group 126 Unlock company profile
Microsoft 96 Unlock company profile
LG 81 Unlock company profile
Stryker 73 Unlock company profile
Alphabet 61 Unlock company profile
Heartflow 58 Unlock company profile
Koninklijke Philips 56 Unlock company profile
Kardium 47 Unlock company profile
InteraXon 45 Unlock company profile
Intel 43 Unlock company profile
Seiko Epson 43 Unlock company profile
Magic Leap 41 Unlock company profile
Beijing Electronics Holding 39 Unlock company profile
Johnson & Johnson 33 Unlock company profile
adidas 33 Unlock company profile
Huawei Investment & Holding 29 Unlock company profile
Proxy 29 Unlock company profile
Demant 27 Unlock company profile
Asahi Kasei 26 Unlock company profile
Xiaomi 25 Unlock company profile
Medtronic 22 Unlock company profile
Siemens 22 Unlock company profile
Meta Platforms 21 Unlock company profile
Xperi Holding 20 Unlock company profile
DexCom 20 Unlock company profile
Mitsubishi Electric 20 Unlock company profile
General Motors 18 Unlock company profile
Tata Sons Pvt 18 Unlock company profile
International Business Machines 17 Unlock company profile
Bose 17 Unlock company profile
Abbott Laboratories 17 Unlock company profile
Movano 16 Unlock company profile
Denso 16 Unlock company profile
Panasonic 16 Unlock company profile
Boston Scientific 16 Unlock company profile
Motorola Mobility 16 Unlock company profile
General Electric 16 Unlock company profile
Beijing Zhigu Rui Tuo Tech 16 Unlock company profile
Life Corp 16 Unlock company profile
Zimmer Biomet Holdings 15 Unlock company profile
Polar Electro 15 Unlock company profile
X Development 14 Unlock company profile
PT Soho Global Health 14 Unlock company profile
Pison Technology 14 Unlock company profile
MindMaze 14 Unlock company profile
InnerEye 14 Unlock company profile
Ricoh 14 Unlock company profile

Source: GlobalData Patent Analytics

Samsung Group is one of the leading patent filers in the field of remote EEG/ECG monitoring. Some other key patent filers in the field include Apple and NIKE.

In terms of application diversity, Microsoft leads the pack, followed by InnerEye and adidas. By means of geographic reach, Stryker held the top position, followed by NIKE and Life Corp in second and third spots, respectively.

The demand for remote EEG/ECG monitoring is being driven by ageing population, growing adoption of telehealth in light of COVID-19 pandemic, technological advancements, and rising awareness of the advantages of remote patient monitoring. Owing to increased prevalence of cardiovascular and neurological diseases, the market for remote EEG/ECG monitoring is anticipated to grow significantly.

To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.